Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Oct. 31, 2025	Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net income	$ 374,900,000	$ 392,300,000	$ 294,200,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	377,400,000	375,100,000	367,700,000
Share-based compensation expense	70,500,000	75,100,000	62,100,000
Non-cash operating lease expense	45,600,000	38,700,000	40,000,000.0
Other including asset impairment charges	77,300,000	42,900,000	49,400,000
Change in fair value of contingent consideration	0	0	(31,800,000)
Deferred income taxes	135,200,000	118,900,000	44,700,000
Change in assets and liabilities:
Accounts receivable	(120,300,000)	(117,100,000)	(60,200,000)
Inventories	(46,000,000.0)	(59,300,000)	(105,400,000)
Other assets	(74,500,000)	(132,500,000)	(89,400,000)
Operating lease right-of-use assets and liabilities, net	(46,800,000)	(42,400,000)	(34,200,000)
Accounts payable	8,000,000.0	9,300,000	5,500,000
Accrued liabilities	27,900,000	3,600,000	71,800,000
Accrued income taxes	(51,700,000)	(15,400,000)	(500,000)
Other long-term liabilities	18,600,000	20,100,000	(6,400,000)
Net cash provided by operating activities	796,100,000	709,300,000	607,500,000
Cash flows from investing activities:
Purchases of property, plant and equipment	(362,400,000)	(421,200,000)	(392,500,000)
Acquisitions of businesses and assets, net of cash acquired, and other	(10,500,000)	(343,400,000)	(56,500,000)
Net cash used in investing activities	(372,900,000)	(764,600,000)	(449,000,000.0)
Cash flows from financing activities:
Proceeds from long-term debt, net of issuance costs	3,111,100,000	3,524,200,000	2,124,200,000
Repayments of long-term debt	(3,205,200,000)	(3,506,800,000)	(1,953,900,000)
Net proceeds from (repayments of) short-term debt, other	14,200,000	(11,800,000)	(351,100,000)
Repurchase of common stock	(290,100,000)	0	0
Proceeds related to share-based compensation awards	5,400,000	55,600,000	15,100,000
Payments related to share-based compensation awards	(24,800,000)	(30,300,000)	(13,100,000)
Dividends on common stock	0	0	(3,000,000.0)
Issuance of common stock for employee stock purchase plan	10,600,000	8,300,000	7,900,000
Acquisition installment payment	(47,100,000)	0	0
Net cash provided (used in) by financing activities	(425,900,000)	39,200,000	(173,900,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	5,600,000	2,900,000	(2,300,000)
Net increase (decrease) in cash, cash equivalents and restricted cash	2,900,000	(13,200,000)	(17,700,000)
Cash, cash equivalents, restricted cash and cash held for sale at beginning of year	107,700,000	120,900,000	138,600,000
Cash, cash equivalents and restricted cash at end of year	110,600,000	107,700,000	120,900,000
Supplemental disclosures of cash flow information:
Interest	115,100,000	134,800,000	117,500,000
Income taxes	100,000,000.0	78,400,000	67,800,000
Operating lease liabilities	49,900,000	48,000,000.0	47,500,000
Operating lease ROU assets obtained in exchange for lease obligations	52,700,000	54,600,000	42,600,000
Reconciliation of cash flow information:
Cash and cash equivalents	110,600,000	107,600,000	120,800,000
Restricted cash included in other current assets	0	100,000	100,000
Total cash, cash equivalents, restricted cash and cash held for sale	$ 110,600,000	$ 107,700,000	$ 120,900,000